MRNA
Moderna Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · Nasdaq Composite 0.04% · S&P 500 0.04% · Russell 1000 0.04% · Russell 3000 0.04% · US Stock Market 0.03%$143.97+5.38%
as of market close, Sep 11, 2026
☾ AH $144.48 +0.35%
MRNA — Moderna Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
50.0100.0150.0200.0250.0300.0350.0400.0450.00200.0M$143.97—20182020202220242026
2026-09-11
Price$143.97
MA20$79.96
MA50$58.61
Vol23.2M
Key stats
Price data
- Price
- $143.97
- Change YTD
- +388.20%
- Next earnings
- Nov 5, 2026
- Market cap
- 57.5B
- Enterprise value
- 57B
- Shares outstanding
- 399.2M
- 52W low
- $22.28
- 52W high
- $176.66
- From 52W high
- -18.50%
- From 52W low
- +546.18%
- 52W range
- 79%
- Beta
- 0.88
Volume
- Rel volume
- 0.62×
- 30D volume
- 24.9M
- 30D $ vol
- 3.6B
Fundamentals
- Sales (ttm)
- 2.2B
- Sales/share
- $5.58
- EPS (ttm)
- -$8.00
- FCF (ttm)
- -1.2B
- FCF/share
- -$3.12
- Book value/share
- $16.93
- Net margin
- -141.43%
- ROE
- -46.61%
- ROA
- -28.75%
- Debt / equity
- 0.09×
- Current ratio
- 2.29
Growth (CAGR, ttm) · 10Y
- Sales
- -27.63%-40.64%-20.51%+37.49%
- Shares
- +2.61%+1.61%-0.22%n/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- -29.47%-41.58%-20.33%n/a
- Book value/share
- -29.91%-27.55%+0.39%n/a
- Price
- +467.71%+10.81%-20.35%n/a
- Total return
- +467.71%+10.81%-20.35%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -18.0×
- Fwd P/E
- -31.4×
- P/S (ttm)
- 25.8×
- P/B (mrq)
- 8.5×
- EV/Sales (ttm)
- 25.6×
- FCF yield (ttm)
- -2.16%
- Buyback yield (realized, 1y)
- -2.61%
- Shareholder yield (realized, 1y)
- -2.61%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/S
- 69th
- P/B
- 77th
Bar = where today’s multiple sits in MRNA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · windows as of 2026-09-11
1D
+5.38%
5D
-3.29%
1M
+126.12%
3M
+190.03%
YTD
+388.20%
1Y
+492.23%
5Y
-63.80%
Financial statements
Open full MRNA financials →Loading financial statements…
Related Healthcare
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -8.44% | -0.65% |
| JNJ | Johnson & Johnson | +2.31% | -0.29% |
| ABBV | AbbVie Inc. | +3.36% | +0.83% |
| MRK | Merck & Co. Inc. | +8.28% | -0.54% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -6.53% | -2.37% |
| TMO | Thermo Fisher Scientific Inc. | +1.13% | +1.10% |
| AMGN | Amgen Inc. | -8.80% | -1.34% |
| GILD | Gilead Sciences Inc. | +5.78% | -0.75% |
Moderna Inc. (MRNA) trades at $143.97 with a live price and an interactive chart covering 7+ years of daily price history, plus key valuation metrics. ChartRow also publishes MRNA’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full MRNA financial statements →
